CeriBell's AI-powered EEG system offers rapid seizure diagnosis. The stock is undervalued by at least 50% over the long-term, ...
A new treatment option has become available for severe epilepsy: fenfluramine, which is now available on the NHS ...
Based on alignment gained with FDA under the Regenerative Medicine Advanced Therapy (RMAT) designation, Neurona plans to conduct the Phase 3 ...
NICE has approved another epilepsy treatment for Lennox–Gastaut syndrome. Fenfluramine can be used as an add-on to other ...
New life-changing treatment option fenfluramine recommended for type of rare epilepsy, Lennox–Gastaut syndrome ...
The talent of Wolfgang Amadeus Mozart, the famous Austrian composer, still captivates many audiences. Classical music lovers ...
Hundreds of children with a rare and severe form of epilepsy are hoping a new drug being rolled out on the NHS may provide a ...
Hundreds of children in England with a rare and severe form of epilepsy are set to benefit from a new drug being rolled out ...
In exchange for $165 million, Biogen now has access to zorevunersen, a potential first-of-its-kind treatment for Dravet ...
Stoke Therapeutics Inc. and Biogen Inc. said Tuesday they are entering a collaboration to develop and commercialize a ...
Under the terms of the deal, Bedford, Mass.-based Stoke (STOK) will retain exclusive rights for the treatment called zorevunersen in the U.S., Canada and Mexico, while Cambridge, Mass.-based Biogen ...
Southern Methodist University biology researchers are uncovering how brain, heart, and lung connections may hold the key to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback